Trupanion Inc (NYSE:TRUP) CFO Tricia Plouf sold 1,000 shares of the business’s stock in a transaction on Tuesday, November 7th. The shares were sold at an average price of $32.11, for a total transaction of $32,110.00. Following the sale, the chief financial officer now directly owns 14,000 shares of the company’s stock, valued at approximately $449,540. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Shares of Trupanion Inc (NYSE TRUP) traded down $0.03 during trading on Friday, reaching $29.95. 66,610 shares of the company traded hands, compared to its average volume of 229,598. Trupanion Inc has a one year low of $13.71 and a one year high of $33.00.

Trupanion (NYSE:TRUP) last announced its quarterly earnings results on Thursday, November 2nd. The financial services provider reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.03) by $0.04. The business had revenue of $63.12 million for the quarter, compared to analysts’ expectations of $61.44 million. Trupanion had a net margin of 0.71% and a return on equity of 3.57%. The business’s quarterly revenue was up 30.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.06) EPS.

COPYRIGHT VIOLATION WARNING: “Tricia Plouf Sells 1,000 Shares of Trupanion Inc (TRUP) Stock” was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.watchlistnews.com/tricia-plouf-sells-1000-shares-of-trupanion-inc-trup-stock/1693643.html.

A number of equities research analysts have recently issued reports on the stock. Zacks Investment Research raised shares of Trupanion from a “hold” rating to a “buy” rating and set a $29.00 price objective for the company in a research report on Wednesday, October 4th. BidaskClub downgraded shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Friday. Canaccord Genuity reissued a “buy” rating and set a $35.00 price objective (up previously from $29.00) on shares of Trupanion in a research report on Tuesday, October 31st. Cowen and Company reissued an “outperform” rating and set a $28.00 price objective (up previously from $19.00) on shares of Trupanion in a research report on Wednesday, August 2nd. Finally, Stifel Nicolaus reissued a “buy” rating and set a $24.00 price objective (up previously from $18.00) on shares of Trupanion in a research report on Wednesday, August 2nd. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $28.83.

A number of hedge funds have recently made changes to their positions in the business. Wells Fargo & Company MN lifted its stake in Trupanion by 173.7% in the 3rd quarter. Wells Fargo & Company MN now owns 30,819 shares of the financial services provider’s stock worth $813,000 after purchasing an additional 19,558 shares in the last quarter. JPMorgan Chase & Co. purchased a new stake in Trupanion in the 3rd quarter worth $143,000. EAM Investors LLC raised its position in shares of Trupanion by 113.9% during the 3rd quarter. EAM Investors LLC now owns 94,836 shares of the financial services provider’s stock valued at $2,505,000 after buying an additional 50,507 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Trupanion by 3.2% during the 3rd quarter. Bank of New York Mellon Corp now owns 77,182 shares of the financial services provider’s stock valued at $2,038,000 after buying an additional 2,382 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Trupanion during the 3rd quarter valued at about $395,000.

About Trupanion

Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.

Insider Buying and Selling by Quarter for Trupanion (NYSE:TRUP)

Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.